Shedding Light on Chemoresistance: The Perspective of Photodynamic Therapy in Cancer Management

Int J Mol Sci. 2024 Mar 29;25(7):3811. doi: 10.3390/ijms25073811.

Abstract

The persistent failure of standard chemotherapy underscores the urgent need for innovative and targeted approaches in cancer treatment. Photodynamic therapy (PDT) has emerged as a promising photochemistry-based approach to address chemoresistance in cancer regimens. PDT not only induces cell death but also primes surviving cells, enhancing their susceptibility to subsequent therapies. This review explores the principles of PDT and discusses the concept of photodynamic priming (PDP), which augments the effectiveness of treatments like chemotherapy. Furthermore, the integration of nanotechnology for precise drug delivery at the right time and location and PDT optimization are examined. Ultimately, this study highlights the potential and limitations of PDT and PDP in cancer treatment paradigms, offering insights into future clinical applications.

Keywords: cancer; chemoresistance; chemotherapy; nanotechnology; photodynamic priming (PDP); photodynamic therapy (PDT).

Publication types

  • Review

MeSH terms

  • Antineoplastic Protocols
  • Cell Death
  • Drug Delivery Systems
  • Drug Resistance, Neoplasm
  • Humans
  • Neoplasms* / drug therapy
  • Photochemotherapy*